BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16760360)

  • 1. Pharmacological targeting of adipocytes/fat metabolism for treatment of obesity and diabetes.
    Pilch PF; Bergenhem N
    Mol Pharmacol; 2006 Sep; 70(3):779-85. PubMed ID: 16760360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptors as therapeutic targets for obesity and type 2 diabetes.
    Bjenning C; Al-Shamma H; Thomsen W; Leonard J; Behan D
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1051-62. PubMed ID: 15535426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible anti-obesity therapeutics from nature--a review.
    Yun JW
    Phytochemistry; 2010 Oct; 71(14-15):1625-41. PubMed ID: 20732701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons that can be learned from patients with diabetogenic mutations in mitochondrial DNA: implications for common type 2 diabetes.
    Maassen JA; 't Hart LM; Ouwens DM
    Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):693-7. PubMed ID: 18089949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging therapies for metabolic diseases--the focus is on diabetes and obesity.
    Hughes TE
    Curr Opin Chem Biol; 2009 Jun; 13(3):332-7. PubMed ID: 19482541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical approaches to the treatment of obesity.
    Jandacek RJ; Woods SC
    Drug Discov Today; 2004 Oct; 9(20):874-80. PubMed ID: 15475320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental origin of fat: tracking obesity to its source.
    Gesta S; Tseng YH; Kahn CR
    Cell; 2007 Oct; 131(2):242-56. PubMed ID: 17956727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin, obesity and diabetes.
    Wiedmer P; Nogueiras R; Broglio F; D'Alessio D; Tschöp MH
    Nat Clin Pract Endocrinol Metab; 2007 Oct; 3(10):705-12. PubMed ID: 17893689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet, obesity and diabetes: a current update.
    Walker CG; Zariwala MG; Holness MJ; Sugden MC
    Clin Sci (Lond); 2007 Jan; 112(2):93-111. PubMed ID: 17155931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of visceral fat accumulation by diabetes mellitus on bone metabolism].
    Oshima K; Shimomura I; Iwahashi H
    Clin Calcium; 2006 Aug; 16(8):1332-42. PubMed ID: 16883042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular targets for new drug discovery to treat type 2 diabetes and obesity].
    Bastarrachea RA; Montero JC; Saavedra-Gajardo I; Cerda-Flores R; Machado-Domínguez A; Comuzzie AG
    Rev Med Chil; 2008 Jan; 136(1):107-17. PubMed ID: 18483661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and systemic functions of bone fat and its contribution to the energy metabolism--the effect of diabetes and obesity on bone.
    Lecka-Czernik B
    J Musculoskelet Neuronal Interact; 2008; 8(4):346-7. PubMed ID: 19147970
    [No Abstract]   [Full Text] [Related]  

  • 14. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ.
    Calabro P; Yeh ET
    Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human obesity and insulin resistance: lessons from experiments of nature.
    O'Rahilly S
    Novartis Found Symp; 2007; 286():13-20; discussion 20-3, 162-3, 196-203. PubMed ID: 18269171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fat cells becoming ever more prolific--editorial].
    Sucharda P
    Vnitr Lek; 2007 Sep; 53(9):928-9. PubMed ID: 18019657
    [No Abstract]   [Full Text] [Related]  

  • 17. Obesity and diabetes: lipids, 'nowhere to run to'.
    Hill MJ; Metcalfe D; McTernan PG
    Clin Sci (Lond); 2009 Jan; 116(2):113-23. PubMed ID: 19076064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-carnitine on obesity, diabetes, and as an ergogenic aid.
    Cha YS
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():306-8. PubMed ID: 18296364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of pancreatic beta-cell function by adipocytes.
    Zhao YF; Chen C
    Sheng Li Xue Bao; 2007 Jun; 59(3):247-52. PubMed ID: 17579776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.